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Abstract
The opioid crisis in the United States has grown at an alarming rate. Children with cancer
are at high risk for pain and opioids are a first-line treatment in this population. Accordingly, there
is an urgent need to optimize pain management in children with cancer without contributing to the
opioid crisis. This report details opportunities for this optimization, including clinical practice
guidelines, comprehensive approaches to pain management, mobile health, and telemedicine. It is
vital to balance appropriate use of analgesics with efforts to prevent misuse in order to reduce
unnecessary suffering and minimize unintended harms.
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The Problem: Opioid Epidemic
The opioid crisis in the United States (U.S.) has grown at an alarming rate, with a 200%
increase in opioid-related overdose deaths since 2000.1 The roots of the opioid epidemic in the
U.S. are multifactorial and largely stem from the routine use of opioid medications to treat acute
pain starting in the 1980’s. This was followed by a shift in the treatment of chronic pain in the
1990’s from cognitive-behavioral therapy as the primary intervention to opioids.2,3 The shift to
managing chronic pain with opioids primarily reflects a significant increase in rates of disabling
chronic pain, patient expectations for a “quick fix,” and a medical system that changed
reimbursement strategies to prioritize the use of simplistic treatment approaches for complex
health problems.2,4 Moreover, a campaign initiated by the American Pain Society in the 1990’s to
include pain as the “fifth vital sign” subsequently led to the adoption of routine measurement of
pain severity in health settings using a numeric rating scale as well as opioid administration based
upon patient pain scores.5 Accordingly, the U.S. is in the midst of an epidemic of opioid misuse,
addiction, and overdose.4
The opioid epidemic extends to the pediatric population, with evidence indicating that
deaths from drug overdose in adolescents more than doubled from 1999 to 2007 and have
continued to rise, with the majority of deaths due to opioid-related drug overdoses.6 Most
adolescents who abuse opioids began with a prescription opioid7 and many transitions that occur
during adolescence, including neurobiological, behavioral, and psychological changes can leave
adolescents vulnerable to both chronic pain and drug use.8,9 Thus, adolescents are a particularly
vulnerable population in the context of the opioid epidemic.
There have been many policy changes and trends over the past decade in an effort to combat
the opioid crisis. These include guidelines for providers who prescribe opioids, prescription-drug
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monitoring programs, and investment into prevention and treatment programs.7 In addition, the
National Institutes of Health (NIH) launched a new scientific initiative to fund research to help
combat the opioid crisis, focusing on prevention and intervention efforts to reduce mortality,
identification of novel interventions to treat opioid addiction, and identification of safe nonaddictive alternatives to the management of chronic pain.10 However, the overwhelming majority
of these programs are focused on adult populations.
The Problem: Pain in Children with Cancer
Every year over 12,000 children will be diagnosed with cancer in the United States11 and
the majority of these children will experience pain, which is one of the most distressing symptoms
reported in this population.12 In fact, after diagnosis with leukemia, the most common childhood
cancer diagnosis, 100% of children reported pain over the course of the first year.13 Pain can be
related to the underlying disease; however, for most children the pain they experience is iatrogenic,
or caused by the treatment itself.14,15 Parents have identified pain as the “most problematic”
symptom children experience during cancer treatment16 and children have described pain as the
most distressing and frightening aspect of their cancer experience.17,18 Unfortunately, evidence
suggests that cancer pain and symptoms are seriously under treated in most children, particularly
in the home setting.13,19–23 Pain is not just an issue at diagnosis and during treatment for cancer.
Survivors of cancer are also at high risk for the experience of chronic pain given the effects of
treatments, which include surgery, radiation, and cytotoxic medications.24
With changes to the delivery of healthcare that have occurred, the majority of children now
receive cancer treatment on an outpatient basis.25 This phenomenon is not limited to oncology. In
fact, the majority of healthcare has transitioned to an ambulatory setting, which has increased
patient and family satisfaction,26,27 but has also shifted healthcare provider responsibility for pain
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and symptom management to parents and caregivers. Research by our group and others has shown
that parents significantly under treat children’s pain in the home setting,28 despite raising pain as
a major problem during children’s cancer treatment.16 One parent-related factor that has been
identified in the literature as a potential barrier to children’s pain management at home is parent
attitudes regarding analgesic use for children. For example, parents who endorse concerns about
side effects of analgesics and/or report poor understanding of pain management provide less
analgesic medication for cancer-related pain that children experience in the home setting.29
Unfortunately, these misconceptions are prevalent in parents of children with cancer.30
Parents are tasked with managing chronic pain in patients with cancer, but are not educated
in symptom assessment or use of pharmacological and non-pharmacological interventions. In fact,
there are very few documented interventions focused on parents and caregivers of patients with
cancer.31 With regard to pharmacologic strategies, related literature indicates that parents report
using ‘trial and error’ to administer analgesics to children following surgery.32 Considering the
myriad tasks related to pharmacologic pain management, including determining what medication
may be appropriate, when and how to administer the medication, the appropriate dose to use,
determining whether the medication is effective, and monitoring side effects,33 a ‘trial and error’
approach is particularly concerning. Finally, there are a number of effective non-pharmacological
strategies used in pain management, including distraction, mindfulness, or other complementary
approaches. However, these strategies are not often introduced to parents,31 and when they are,
they appear to be administered haphazardly and with varying degrees of success.34
Unfortunately, data regarding opioid use and adherence in patients with cancer is extremely
limited because cancer patients are excluded from almost all guidelines, treatment protocols, and
legislation (both at the state and federal level) focused on the use of opioids. In fact, the Centers
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for Disease Control and Prevention (CDC) released guidelines for opioid prescribing for chronic
pain in 2016 that specifically did not include cancer patients due to concerns regarding the
complexity of cancer-related pain as well as beliefs that opioid misuse was not an issue in patients
with cancer.24 Moreover, the World Health Organization and other national guidelines have
supported the use of opioids in the cancer population.35,36 The support for opioid use in cancer
patients is likely the result of both a perception of the lack of abuse concern and clinical need for
opioid use in the treatment of cancer-related pain. Opioids are often considered to be first-line
analgesics in the oncology setting due to concerns that the use of over-the-counter pain
medications, including acetaminophen and non-steroidal anti-inflammatory medications, may
mask important clinical symptoms such as fever, which can indicate a medical emergency.37 In
fact, the overwhelming majority of children with cancer referred for neuropathic pain in the
outpatient setting were using opioids as either a single agent or in combination with other
analgesics.38 Finally, little is known about patterns of opioid use and misuse in the oncology setting
because patients with cancer are also excluded from clinical trials that focus on chronic pain and
analgesic use.
The Challenge: Optimizing Cancer Pain Management for Children in the Context of the
Opioid Crisis
The question arises, then, how can we optimize the management of pain in children with
cancer without contributing to the opioid crisis? Given that children with cancer are at high risk
for the experience of recurrent pain, both during treatment and throughout survivorship, and that
parents are responsible for the majority of children’s cancer pain management, it is imperative to
equip parents and caregivers with evidence-based strategies to more appropriately manage pain.
These strategies should allow for symptom management at home without placing children,
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particularly adolescents, at risk for opioid misuse. Unfortunately, there is a dearth of research
regarding a best practice model in this context.
Clinical Practice Guidelines
As noted above, current guidelines for opioid prescribing for chronic pain exclude cancer
patients. Additionally, such guidelines fail to include integrative approaches to pain management,
such as complementary and alternative medicine (CAM). In addition, cancer-specific guidelines,
such as those by the American Society of Clinical Oncologists (ASCO) and the National
Comprehensive Cancer Network (NCCN) focus solely on adults and survivors.36,39 The lack of
guidelines for pediatric patients with cancer should be a call to clinicians, investigators, and
professional associations to come together to develop clear guidelines for management of cancer
pain in children and adolescents. Opioid stewardship programs that involve a collaborative effort
of multidisciplinary stakeholders have shown promise in optimizing pain management.40 One
healthcare provider often not included in the management of cancer-related pain is the clinical
pharmacist. Pharmacists can play a vital role in optimizing pain management and improving
medication safety through customizing analgesic medications to the needs of the patient and
clinical context and providing necessary patient education.41
The Need for a Comprehensive Approach to Pain Management
A multidisciplinary approach to pain management is needed, particularly in light of the
opioid crisis. That is, pain management should include a broad repertoire of pharmacologic and
non-pharmacologic strategies. Regarding the latter, the incorporation of integrative medicine (IM)
modalities with conventional strategies is a means of comprehensive, multidisciplinary
treatment.42 IM strategies include evidence-based strategies for pain such as guided imagery,
biofeedback, and acupuncture. Although reports suggest the use of these strategies by pediatric
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oncology patients is high,43 efficacy data for some IM strategies is lacking and long-term
effectiveness has not been well established, particularly in the pediatric population.44 This suggests
a need for rigorous evaluation of the safety and effectiveness of IM interventions, particularly in
the context of pain management for pediatric cancer patients.
Moreover, given the increasing responsibility of parents and caregivers in the role of pain
management, efforts targeting appropriate pain assessment are needed. Despite pain as a major
concern for children and parents, pain assessment throughout cancer treatment is not performed
systematically.45 Moreover it has been documented that parents of children with cancer report
misconceptions about how children express pain, including beliefs that children will always report
when they are in pain and children who are playing or otherwise engaged cannot be in pain.30
Further, there are no validated parental assessments of children’s pain severity in the oncology
setting. Thus, efforts are needed to adequately equip parents in understanding proper assessment
of children’s cancer-related pain as well as development of validated parent-report measures of
children’s pain in the oncology setting.
mHealth
Mobile devices have become ubiquitous in the U.S. and nearly 80% of Americans own
smartphones.46 Patients and caregivers routinely search for health-related information using their
mobile devices and mobile apps are particularly engaging for pediatric patients living in the current
technology rich environment.47,48 Accordingly, globally, there has been an explosion in mobile
health (mHealth) – the use of mobile devices to assess, monitor, and impact health outcomes.
Although the field of mHealth is not without its challenges,49 it does provide a potential avenue to
deliver pain management to populations more broadly.

8

In fact, in recent years, investigators have harnessed mHealth technology to attempt to
bridge gaps in pain management in pediatric oncology. Our own group has developed Pain Buddy,
an animated, interactive web-based pain and symptom assessment and management program for
children and adolescents aged 8-18 years undergoing treatment for cancer. Pain Buddy is
comprised of a validated pain and symptom assessment component, an electronic communication
component that provides symptom data to healthcare providers in real time, and cognitive and
behavioral skills training for children (e.g., guided imagery, mindfulness, diaphragmatic
breathing) for pain management.50 Pain Buddy has been shown to be well accepted and feasible
to use by patients and healthcare providers50 and is currently undergoing efficacy testing. Pain
Squad is another app that is used on smartphones for children and adolescents with cancer that
assesses pain severity and characteristics and strategies used to manage pain.51 Pain Squad+ is a
newer iteration of the program that focuses on self-management of cancer-related pain in
adolescents that uses algorithms to provide adolescents with both pharmacological and nonpharmacological pain management strategies.52 Pain Squad+ has improved pain-related outcomes
for children and adolescents with cancer.53,54 Despite evidence supporting the efficacy and
acceptability of these apps, broader dissemination efforts have been limited; thus, efforts focused
on implementation of such programs is necessary in order to have a substantive impact on pediatric
cancer-related pain.
applications

Moreover, in the adult arena, there are many commercially available

targeting

healthcare

in

patients

with

cancer

(e.g.,

https://www.mobihealthnews.com/content/mobile-app-launches-better-connect-cancer-patientsappropriate-care-clinical-trials;

https://www.cancer.net/navigating-cancer-care/managing-your-

care/mobile-applications). Efforts to develop similar resources for the pediatric population and
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include a focus on pain management may be an avenue to bridge the gap in cancer pain
management.
Telemedicine
Telemedicine has been defined as “technology-enabled health and care management and
delivery systems that extend capacity and access.”55 More recently, the benefits of telemedicine
have been recognized by the healthcare community and have been increasingly used to enhance
the accessibility of tertiary care for children, particularly in rural and underserved areas.56,57 In the
adult arena, telemedicine has been shown to be effective for management of multiple cancerrelated symptoms, including pain.58 In pediatric oncology, telemedicine has been utilized to
improve access to care and has been effective in improving cancer-related outcomes.59
Telepharmacy, a more specific application of telemedicine, involves pharmacist-related services
such

as

medication

management,

chronic

disease

management,

care

transition,

pharmacogenomics, and remote dispensing and ambulatory care. In the ambulatory setting,
telepharmacy interventions have improved disease outcomes, patient self-management, and
treatment adherence; however, such interventions have not been assessed in pediatric oncology
patients.60 Utilizing advanced technologies with better decision support and real-time reporting
capabilities, healthcare providers can effectively manage a patient’s symptoms in a timely manner.
For pediatric patients with cancer, telemedicine may provide a cost-effective approach to optimize
pain management in the home setting.
Summary
The opioid epidemic is a national health concern that is not specific to the adult population.
Misuse of opioids extends to the pediatric setting and has particular importance with regard to
pediatric oncology, where pain is prevalent and opioids are often the first-line analgesic used to
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manage cancer-related pain. Despite the high rates of pain in pediatric oncology patients and
potential benefits of opioid use, there is little clinical and policy guidance on opioid use in this
setting. Further, the shift in pain management to the home setting has complicated appropriate
opioid use as parents and caregivers often are not well equipped to assess and manage child pain.
To make progress in this area, multidisciplinary researchers, healthcare providers, and policy
makers need to pave the way in optimizing pain management. Fruitful advancement can come
from creating clinical practice guidelines, testing and implementing integrative approaches to care,
developing systematic pain measurement methods for parents and caregivers to use, and providing
parents and caregivers with best practices in the area of pain management. Capitalizing on
mHealth, Telemedicine, and Telepharmacy could be useful to achieve these goals and allow for
the appropriate use of opioids to treat cancer-related pain in pediatric patients and increase their
quality of life. A vital aspect of this effort is that fear of opioids not lead to the significant under
treatment of children’s cancer pain. Rather, it is critical to develop evidence-based protocols for
management of cancer-related pain in children that reduces unnecessary suffering and minimizes
unintended harms.
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